While it's good news it's also nothing surprising so it's already baked into the current price, not surprised by the lack of action at all.
We've still got years and multiple hurdles until potential revenue. This only confirms that we are on the right track and long term potential is still looking very promising.
Ann: Interim Update on Progress in RP11 Repeat Dose Trials, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.020(1.72%) |
Mkt cap ! $688.2M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.18 | $88.96K | 74.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1789 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 1775 | 4 |
View Market Depth
| Last trade - 14.55pm 17/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |